Literature update

1. RSV maternal vaccine vs infant immunization (Netherlands) Dutch researchers explored how pregnant women view the two new RSV prevention options for infants: a maternal RSV vaccine in pregnancy and an infant monoclonal antibody injection. In a mixed-methods study across 15 antenatal clinics and a tertiary hospital, 412 women completed a survey, and 12 joined focus groups. More than three-quarters expressed a positive attitude towards receiving either option, but nearly 90% said they would choose maternal vaccination if the two were equally safe and effective. Protection of the infant against RSV and perceived safety for the child before and after birth emerged as the dominant drivers of preference, while fear of vaccination or religious beliefs played a minor role. In focus groups, women emphasized trusted advice from health care professionals and a careful balancing of vaccine safety, disease severity and duration of protection, and many said they would switch to the...